FMP

FMP

Enter

QLGN - Qualigen Therap...

photo-url-https://images.financialmodelingprep.com/symbol/QLGN.png

Qualigen Therapeutics, Inc.

QLGN

NASDAQ

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

3.06 USD

0 (0%)

Historical Prices

From:

To:

3.043.053.063.073.083.093.13.1110:36 AM01:24 PM02:53 PM03:00 PM03:12 PM03:49 PM03:59 PM

About

ceo

Mr. Kevin A. Richardson II

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in...

CIK

0001460702

ISIN

US74754R2022

CUSIP

74754R103

Address

2042 Corte Del Nogal

Phone

760 918 9165

Country

US

Employee

4

IPO Date

Jun 23, 2015

Financial Statement

-4M-2M02M4M6M8M2023 Q32023 Q42024 Q12024 Q22024 Q3RevenueNet Income

Earnings

-50-40-30-20-1002023 Q12023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q4EPS Consensus

QLGN Financial Summary

CIK

0001460702

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

74754R103

ISIN

US74754R2022

Country

US

Price

3.06

Beta

0.11

Volume Avg.

49.04k

Market Cap

2.25M

Shares

-

52-Week

2.96-29.45

DCF

-0.18

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-

P/B

-

Website

https://www.qualigeninc.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest QLGN News

InvestorPlace

Jul 15, 2024

Why Is Qualigen Therapeutics (QLGN) Stock Down 22% Today?

Qualigen Therapeutics (NASDAQ: QLGN ) stock is falling on Monday as the clinical-stage therapeutics company's shares come off of a massive rally on Friday. That Friday rally resulted in shares of QLGN stock closing out normal trading hours up 109.2%.

InvestorPlace

Jul 12, 2024

Why Is Qualigen (QLGN) Stock Up 141% Today?

Qualigen (NASDAQ: QLGN ) stock is rocketing higher on Friday after the clinical-stage therapeutics company secured a new loan. Qualigen reached an agreement with an investor for a $2 million Senior Note due July 8, 2025 with an 18% annual interest rate.

InvestorPlace

Jul 8, 2024

Why Is Qualigen Therapeutics (QLGN) Stock Down 12% Today?

Qualigen Therapeutics (NASDAQ: QLGN ) stock is sliding lower on Monday as the clinical-stage therapeutics company's shares come off of a rally on Friday. That rally saw shares of QLGN stock soar more than 59% higher during normal trading hours.

GlobeNewsWire

Mar 15, 2023

Qualigen Therapeutics to Present Five Posters at the America...

CARLSBAD, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces the Company will be presenting five posters at the American Association for Cancer Research (AACR) Annual Meeting 2023 to be held April 14-19 in Orlando, FL. The AACR Confer...

GlobeNewsWire

Jun 14, 2022

Qualigen Therapeutics to Present at BIO International Conven...

CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics will present a corporate overview at the BIO International Convention to be held on June 13 – 16, 2022 at the San Diego Convention Center.

GlobeNewsWire

May 20, 2022

Qualigen Therapeutics to Present at the H.C. Wainwright Glob...

CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today announces that Qualigen Therapeutics Management will present a corporate overview during the H.C. Wainwright Global Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hote...

GlobeNewsWire

May 10, 2022

Qualigen Therapeutics' Partner NanoSynex to Present Technolo...

Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold

PennyStocks

Apr 12, 2022

Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today

Check these 3 under $1 biotech penny stocks out for your list The post Top Biotech Penny Stocks to Buy Under $1? 3 Exploding Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep